180 related articles for article (PubMed ID: 2795281)
1. Persistent pulmonary hypertension after heterotopic heart transplantation: a case report.
Shumway SJ; Baughman KL; Traill TA; Cameron DE; Fonger JD; Gardner TJ; Achuff SC; Reitz BA; Baumgartner WA
J Heart Transplant; 1989; 8(5):387-90. PubMed ID: 2795281
[TBL] [Abstract][Full Text] [Related]
2. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
Liu MZ; Wang JH; Du J; Huang J; Li LH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
[TBL] [Abstract][Full Text] [Related]
3. Cardiac transplant recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options.
Kawaguchi A; Gandjbakhch I; Pavie A; Bors V; Muneretto C; Leger P; Mestiri T; Piazza C; Cabrol A; Desruennes M
Circulation; 1989 Nov; 80(5 Pt 2):III90-6. PubMed ID: 2805309
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation.
Zales VR; Pahl E; Backer CL; Crawford S; Mavroudis C; Benson DW
J Heart Lung Transplant; 1993; 12(6 Pt 1):965-72; discussion 972-3. PubMed ID: 8312321
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting survival after heterotopic heart transplantation.
Kawaguchi A; Gandjbakhch I; Pavie A; Muneretto C; Bors V; Leger P; Cabrol A; Desruennes M; Cabrol C
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):928-34. PubMed ID: 2811423
[TBL] [Abstract][Full Text] [Related]
7. Heterotopic heart transplantation for elevated pulmonary vascular resistance in pediatric patients.
Cochrane AD; Adams DH; Radley-Smith R; Khaghani A; Yacoub MH
J Heart Lung Transplant; 1995; 14(2):296-301. PubMed ID: 7779849
[TBL] [Abstract][Full Text] [Related]
8. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year.
Chau EM; Bailey KR; Mahoney DW; Frantz RP; McGregor CG; Daly RC; Edwards BS; Olson LJ; Rodeheffer RJ
Circulation; 1996 Nov; 94(9 Suppl):II267-72. PubMed ID: 8901758
[TBL] [Abstract][Full Text] [Related]
9. Heterotopic heart transplantation in 1988--recent selective indications and outcome.
Reichenspurner H; Hildebrandt A; Boehm D; Kaulbach HG; Willems S; Odell JA; Horak A; Reichart B
J Heart Transplant; 1989; 8(5):381-6. PubMed ID: 2795280
[TBL] [Abstract][Full Text] [Related]
10. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study.
Martin J; Siegenthaler MP; Friesewinkel O; Fader T; van de Loo A; Trummer G; Berchtold-Herz M; Beyersdorf F
Eur J Cardiothorac Surg; 2004 Jun; 25(6):971-7. PubMed ID: 15144997
[TBL] [Abstract][Full Text] [Related]
11. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension.
Chen EP; Bittner HB; Davis RD; Van Trigt P
Ann Thorac Surg; 1997 Jun; 63(6):1546-55. PubMed ID: 9205146
[TBL] [Abstract][Full Text] [Related]
12. Massive degeneration and atrophy of the native heart after heterotopic transplantation: a case report.
Fiorelli AI; Coelho GH; Lima JL; Lourenço DD; Gutierres P; Bacal F; Bocchi E; Dias RR; Stolf NA
Transplant Proc; 2009 Apr; 41(3):965-6. PubMed ID: 19376400
[TBL] [Abstract][Full Text] [Related]
13. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
14. Managing pulmonary hypertension in heart transplantation: meeting the challenge.
Coe PF
Crit Care Nurse; 2000 Apr; 20(2):22-8; quiz 29-30. PubMed ID: 11873750
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
Iberer F; Wasler A; Tscheliessnigg K; Petutschnigg B; Auer T; Müller H; Rödl S
J Heart Lung Transplant; 1993; 12(2):173-8. PubMed ID: 8476887
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
[TBL] [Abstract][Full Text] [Related]
17. Heterotopic heart transplantation: current status in 1988.
Desruennes M; Muneretto C; Gandjbakhch I; Kawaguchi A; Pavie A; Bors V; Piazza C; Rabago G; Leger P; Vaissier E
J Heart Transplant; 1989; 8(6):479-85. PubMed ID: 2614550
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary hypertension and early mortality after orthotopic heart transplantation].
López-Ciudad VJ; López Pérez JM; Fojón Polanco S; Blanco Sierra FJ; Pradas Montilla G; Cuenca Castillo JJ; Vázquez González N; Hermida Alvarez LF
Rev Esp Cardiol; 1995 Aug; 48(8):552-6. PubMed ID: 7644809
[TBL] [Abstract][Full Text] [Related]
19. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
Chang PP; Longenecker JC; Wang NY; Baughman KL; Conte JV; Hare JM; Kasper EK
J Heart Lung Transplant; 2005 Aug; 24(8):998-1007. PubMed ID: 16102433
[TBL] [Abstract][Full Text] [Related]
20. Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease.
Collins MH; Darragh RK; Caldwell RL; Turrentine MW; Brown JW
J Heart Lung Transplant; 1995; 14(6 Pt 1):1116-25. PubMed ID: 8719459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
